Gabapentin and inflammation
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Anti-Inflammatory Effects: Mechanisms and Evidence
Gabapentin and Inflammatory Pathways
Gabapentin, widely known as an anticonvulsant and for treating neuropathic pain, has shown significant anti-inflammatory effects in various experimental models. Its anti-inflammatory action is closely linked to the regulation of key inflammatory pathways, particularly through the activation of the peroxisome proliferator-activated receptor gamma (PPAR-γ). This activation leads to the inhibition of nuclear factor kappa B (NFκB), a central regulator of inflammation, resulting in reduced expression of inflammatory genes and mediators such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) De Brito2020Li2024.
Evidence from Animal Models: Intestinal, Cardiac, and Airway Inflammation
In animal studies, gabapentin has been shown to reduce both macroscopic and microscopic signs of inflammation in models of colitis, with effects lost when PPAR-γ is inhibited, confirming the importance of this pathway . Similarly, in models of myocardial infarction, gabapentin reduced pro-inflammatory markers, promoted anti-inflammatory macrophage polarization, and improved cardiac function and tissue remodeling, again via PPAR-γ activation .
Gabapentin also demonstrated anti-inflammatory and anti-allergic effects in a mouse model of asthma, where it reduced inflammatory cell counts, oxidative stress, and levels of cytokines such as TNF-α, IL-4, and IL-13, leading to improved lung histopathology . In a guinea pig model of gastroesophageal reflux-related cough, gabapentin reduced cough hypersensitivity and neurogenic inflammation by lowering substance P levels in the airways and vagal ganglia .
Reduction of Inflammatory Mediators and Oxidative Stress
Gabapentin consistently reduced the action of various inflammatory mediators, neutrophil migration, and pro-inflammatory cytokine levels in multiple models, including paw edema and peritonitis in mice. It also exhibited antioxidant properties by decreasing malondialdehyde (MDA) and increasing glutathione (GSH) content, suggesting a role in protecting tissues from oxidative damage during inflammation Dias2014Yosri2018.
Gabapentin in Ocular and Neurogenic Inflammation
Topical gabapentin reduced clinical signs and biomarkers of ocular inflammation in rabbit models of endotoxin-induced uveitis, decreasing cytokine production and inflammatory enzyme expression . In neurogenic inflammation, gabapentin reduced the release of sensory neuropeptides such as substance P and calcitonin gene-related peptide, but only after inflammation or protein kinase C activation, indicating its effects are more pronounced in sensitized or inflamed tissues Fehrenbacher2003Stanfa1997.
Human Studies and Clinical Implications
In human studies, gabapentin did not show analgesic effects in normal skin but reduced primary mechanical allodynia in acute inflammation following thermal injury, suggesting potential for treating postoperative or inflammatory pain . Gabapentin and its derivatives have also been shown to reduce inflammatory edema and pyrexia in animal models, with mechanisms involving both opioidergic and GABAergic pathways .
Conclusion
Gabapentin exhibits broad anti-inflammatory effects across various tissues and models, primarily by modulating key inflammatory pathways such as PPAR-γ and NFκB, reducing pro-inflammatory cytokines, and limiting oxidative stress. Its effects are most notable in inflamed or sensitized tissues, supporting its potential use in treating inflammatory conditions beyond its established roles in neuropathic pain and epilepsy De Brito2020Dias2014Anfuso2017+5 MORE.
Sources and full results
Most relevant research papers on this topic